PE20070640A1 - Compuestos derivados de pirazol-isoquinolina urea como inhibidores de la cinasa p38 - Google Patents

Compuestos derivados de pirazol-isoquinolina urea como inhibidores de la cinasa p38

Info

Publication number
PE20070640A1
PE20070640A1 PE2006001274A PE2006001274A PE20070640A1 PE 20070640 A1 PE20070640 A1 PE 20070640A1 PE 2006001274 A PE2006001274 A PE 2006001274A PE 2006001274 A PE2006001274 A PE 2006001274A PE 20070640 A1 PE20070640 A1 PE 20070640A1
Authority
PE
Peru
Prior art keywords
urea
pirazol
methyl
isoquinolin
isoquinoline
Prior art date
Application number
PE2006001274A
Other languages
English (en)
Inventor
Chuan Shih
Cristina Garcia-Paredes
De Uralde Garmendia Beatriz Lopez
Dios Alfonso De
Mary Margaret Mader
Mark Andrew Pobanz
Boyu Zhong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43298632&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070640(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20070640A1 publication Critical patent/PE20070640A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIRAZOL-ISOQUINOLINA UREA DE FORMULA (I) DONDE X ES UN COMPUESTO DE FORMULA (i) O (ii), DONDE R3 ES AMINO, ALQUILO(C1-C4), ALCOXI(C1-C4), ALQUILHALO(C1-C4), ENTRE OTROS; R1 ES ALQUILO(C1-C4), ALQUILHALO(C1-C4) O CICLOALQUILO(C3-C4) OPCIONALMENTE SUSTITUIDO CON ALCOXI(C1-C4), METILO O TRIFLUOROMETILO; R2 ES FENILO O PIRIDINILO OPCIONALMENTE SUSTITUIDOS CON ALQUILO(C1-C4). SON COMPUESTOS PREFERIDOS: MESILATO DE 1-{1-[4-(2,2-DIMETIL-PROPIONIL)-PIPERAZIN-1-IL]-ISOQUINOLIN-4-IL}-3-[5-(1-METIL-CICLOPROPIL)-2-p-TOLIL-2H-PIRAZOL-3-IL]-UREA, MESILATO DE 1-[5-TERC-BUTIL-2-(6-METIL-PIRIDIN-3-IL)-2H-PIRAZOL-3-IL]-{1-[1-(1-METIL-CICLOPROPANCARBONIL)-PIPERIDIN-4-ILOXI]-ISOQUINOLIN-4-IL}-UREA, MESILATO DE 1-{1-[1-(2-FLUORO-BENZOIL)-PIPERIDIN-4-ILOXI]-ISOQUINOLIN-4-IL}-3-[5-(1-METOXI-CICLOPROPIL)-2-p-TOLIL-2H-PIRAZOL-3-IL]-UREA. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA CINASA P38 SIENDO UTILES EN EL TRATAMIENTO DE ARTRITIS REUMATOIDE, OSTEOARTRITIS, ATEROESCLEROSIS, INSUFICIENCIA CARDIACA CRONICA
PE2006001274A 2005-10-28 2006-10-20 Compuestos derivados de pirazol-isoquinolina urea como inhibidores de la cinasa p38 PE20070640A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05380240 2005-10-28
US75020005P 2005-12-14 2005-12-14
EP06380097 2006-04-26
US82196406P 2006-08-10 2006-08-10

Publications (1)

Publication Number Publication Date
PE20070640A1 true PE20070640A1 (es) 2007-08-10

Family

ID=43298632

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001274A PE20070640A1 (es) 2005-10-28 2006-10-20 Compuestos derivados de pirazol-isoquinolina urea como inhibidores de la cinasa p38

Country Status (13)

Country Link
US (1) US7582638B2 (es)
EP (1) EP1943244A1 (es)
JP (1) JP2009513639A (es)
KR (1) KR101013303B1 (es)
AR (1) AR058128A1 (es)
AU (1) AU2006309174B2 (es)
BR (1) BRPI0617828A2 (es)
CA (1) CA2627670A1 (es)
DO (1) DOP2006000233A (es)
EA (1) EA015123B1 (es)
PE (1) PE20070640A1 (es)
TW (1) TW200800194A (es)
WO (1) WO2007053346A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008125014A1 (fr) * 2007-04-13 2008-10-23 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. Composés d'urée, leurs procédés de préparation et leurs utilisations pharmaceutiques
EP2039676A1 (en) * 2007-09-19 2009-03-25 Huntsman International Llc Process for the production of di-and polyamines of the diphenylmethane series
PL2763984T3 (pl) 2011-10-03 2016-10-31 1-pirazolilo-3-(4-((2-anilinopirymidyno-4-ilo)oksy)naftaleno-1-ilo)moczniki jako inhibitory kinazy p38 MAP
EP2578582A1 (en) 2011-10-03 2013-04-10 Respivert Limited 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors
GB201214750D0 (en) 2012-08-17 2012-10-03 Respivert Ltd Compounds
EP2925742B1 (en) 2012-11-16 2016-10-26 Respivert Limited Kinase inhibitors
WO2014140582A1 (en) 2013-03-14 2014-09-18 Respivert Limited Kinase inhibitors
MX2019010302A (es) 2017-03-30 2019-11-21 Hoffmann La Roche Isoquinolinas como inhibidores de hpk1.
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
LT3691620T (lt) 2017-10-05 2022-09-26 Fulcrum Therapeutics, Inc. P38 kinazės inhibitoriai, sumažinantys dux4 ir pasrovinių genų raišką, skirti fshd gydymui
US11612606B2 (en) 2018-10-03 2023-03-28 Genentech, Inc. 8-aminoisoquinoline compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
US20060063782A1 (en) 2002-07-03 2006-03-23 Murray Christopher W 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
WO2006009741A1 (en) * 2004-06-23 2006-01-26 Eli Lilly And Company Kinase inhibitors
EP1609789A1 (en) 2004-06-23 2005-12-28 Eli Lilly And Company Ureido-pyrazole derivatives and their use as kinase inhibitors

Also Published As

Publication number Publication date
EP1943244A1 (en) 2008-07-16
BRPI0617828A2 (pt) 2011-08-09
WO2007053346A1 (en) 2007-05-10
CA2627670A1 (en) 2007-05-10
EA200801200A1 (ru) 2008-08-29
TW200800194A (en) 2008-01-01
DOP2006000233A (es) 2007-06-15
EA015123B1 (ru) 2011-06-30
AU2006309174A1 (en) 2007-05-10
US20080275056A1 (en) 2008-11-06
AR058128A1 (es) 2008-01-23
AU2006309174B2 (en) 2011-10-13
KR20080053514A (ko) 2008-06-13
JP2009513639A (ja) 2009-04-02
KR101013303B1 (ko) 2011-02-09
US7582638B2 (en) 2009-09-01

Similar Documents

Publication Publication Date Title
PE20070640A1 (es) Compuestos derivados de pirazol-isoquinolina urea como inhibidores de la cinasa p38
PE20070795A1 (es) Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa
PE20080890A1 (es) DERIVADOS DE IMIDAZOLONA E IMIDAZOLIDINONA COMO INHIBIDORES DE LA 11b-HSD1 PARA LA DIABETES
PE20051146A1 (es) Compuestos heterociclicos anticitocina
PE20090887A1 (es) DERIVADOS DE 1H-PIRAZOL-[3,4-d]-PIRIMIDINA, 9H-PURINA Y 7H-PIRROL-[2,3-d]-PIRIMIDINA COMO INHIBIDORES DE CINASA P70 S6
PE20091026A1 (es) Piperidinas heteroaril-sustituidas
PE20090815A1 (es) Compuesto de amida
PE20110894A1 (es) Derivados de pirimidin indol para el tratamiento de cancer
PE20110341A1 (es) COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA
NO20084418L (no) Azolopyridin-3-on derivater som inhibitorer av endoteliallipase
NO20070731L (no) Heterocykliske forbindelser.
PE20121045A1 (es) Agonista de gpr119
PE20130239A1 (es) Compuestos heteroaril-aril-ureas como inhibidores de la quinasa
PE20040647A1 (es) Inhibidores de cinasas de tirosina
PE20090886A1 (es) Nuevos inhibidores de quinasa
PE20060427A1 (es) Derivados de pirazol como inhibidores de la union del glucagon y composiciones
PE20110566A1 (es) Inhibidores ciclicos de 11beta-hidroxiesteroide deshidrogenasa 1
PE20141681A1 (es) Inhibidores de btk
PE20140913A1 (es) Inhibidores de nampt y rock
NO20064166L (no) Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
PE20090984A1 (es) Inhibidores de peptido desformilasa
PE20091243A1 (es) Compuesto heterociclico fusionado
PE20090709A1 (es) Compuestos heterociclico de 5 miembros
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
PE20110433A1 (es) Antagonistas de la via hedgehog de ftalazina disustituida

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed